Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avisa Diagnostics Inc FOGCF

Avisa Diagnostics Inc. is a clinical-stage medical device company. The Company is engaged in the development of the Allora BreathTest (ABT), a drug/device biomarker technology platform. The Allora BreathTest (ABT) is an ultra-rapid, point-of-care biomarker breath test for the detection and monitoring of bacterial load. ABT enables the ultra-rapid detection of virulent bacterial pathogens... see more

Recent & Breaking News (GREY:FOGCF)

CSE Bulletin: Delist - Avisa Diagnostics Inc. (AVBT)

Newsfile July 13, 2023

CSE Bulletin: Suspensions (MJRX, AVBT, XRA, GOH, FUZN, BYT)

Newsfile December 6, 2021

IIROC Trading Halt - AVBT

PR Newswire December 6, 2021

Avisa Diagnostics Reports on Status of Interim Filings

GlobeNewswire November 24, 2021

Avisa Diagnostics Appoints Dr. Richard Murray as Chief Medical Officer

GlobeNewswire September 1, 2021

Avisa Diagnostics Announces Closing of Non-Brokered Private Placement of Common Shares

GlobeNewswire August 25, 2021

Avisa Diagnostics Announces Non-Brokered Private Placement of Common Shares

GlobeNewswire August 20, 2021

Avisa Diagnostics Announces Closing of Non-Brokered Private Placement of Common Shares

GlobeNewswire July 19, 2021

Avisa Diagnostics (CSE:AVBT) announces non-brokered private placement

John Ballem  July 12, 2021

Avisa Diagnostics Announces Non-Brokered Private Placement of Common Shares

GlobeNewswire July 12, 2021

Avisa Diagnostics to Participate at Upcoming Investor Events

GlobeNewswire July 9, 2021

Avisa Diagnostics Appoints G. Michael Landis as Chief Financial Officer

GlobeNewswire June 22, 2021

Avisa Diagnostics to Participate in Renmark's Virtual Non-Deal Roadshow Series on June 17, 2021

GlobeNewswire June 17, 2021

Avisa Diagnostics Appoints Barbara Bunger, PhD as Vice President, Clinical Development

GlobeNewswire June 2, 2021

Avisa Diagnostics Retains Venture Liquidity Providers Inc. for Market-Making Services

GlobeNewswire May 26, 2021

Avisa Diagnostics Begins Trading on the Canadian Securities Exchange

GlobeNewswire May 18, 2021

IIROC Trade Resumption - AVBT

Canada NewsWire May 17, 2021

CSE Bulletin: Fundamental Change - FogChain Corp./Avisa Diagnostics Inc.

Newsfile May 14, 2021

FogChain Announces Shares For Debt Settlement

Canada NewsWire April 15, 2021

FogChain Announces Definitive Agreement for the Acquisition of Avisa Pharma Inc.

Canada NewsWire February 2, 2021